These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 4091884)

  • 1. Blood lipid profile in healthy subjects treated with ticlopidine.
    Violi F; Alessandri C; Iuliano L; Ghiselli A; Perrone A; Balsano F
    Atherosclerosis; 1985 Dec; 58(1-3):291-4. PubMed ID: 4091884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spin label study of the effect of ticlopidine on platelets.
    Hongo T; Setaka M; Kwan T
    Jpn J Pharmacol; 1985 Sep; 39(1):59-66. PubMed ID: 2999489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ex vivo effects of ticlopidine on human platelets: inhibition of fibrinogen binding by a mechanism independent of thromboxane formation.
    Iovine C; d'Avenia V; Turco S; Mattioli PL; di Minno G
    Agents Actions Suppl; 1984; 15():105-7. PubMed ID: 6592941
    [No Abstract]   [Full Text] [Related]  

  • 4. [The antiaggregation effect of ticlopidine on blood platelets preliminary results and prospectives for studies in various diseases].
    Andriani A; Chiappetta MG; Fabiani M; Mosiello G; Beni A
    Clin Ter; 1983 Feb; 104(3):219-22. PubMed ID: 6345050
    [No Abstract]   [Full Text] [Related]  

  • 5. [Experimental study of the effect of ticlopidine chlorhydrate on the development of atherosclerotic lesions].
    Viver Manresa E; Huguet Redecilla P
    Angiologia; 1986; 38(3):134-49. PubMed ID: 3740536
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of oral ticlopidine on arachidonic acid products in human platelets.
    Bruno JJ; Chang LF; McSpadden MM; Yang D
    Agents Actions Suppl; 1984; 15():76-87. PubMed ID: 6435408
    [No Abstract]   [Full Text] [Related]  

  • 7. [Thrombocytopenia due to antibodies induced by ticlopidine].
    Claas FH; de Fraiture WH; Meyboom RH
    Nouv Rev Fr Hematol (1978); 1984; 26(5):323-4. PubMed ID: 6504695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of ticlopidine on platelet functions in acute myocardial infarction. A double blind controlled trial.
    Knudsen JB; Kjøller E; Skagen K; Gormsen J
    Thromb Haemost; 1985 Jun; 53(3):332-6. PubMed ID: 3901391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of ticlopidine on blood fibrinogen and blood viscosity in peripheral atherosclerotic disease.
    Randi ML; Fabris F; Crociani ME; Battocchio F; Girolami A
    Arzneimittelforschung; 1985; 35(12):1847-9. PubMed ID: 4096744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of platelet aggregation in patients treated with ticlopidine].
    Sbalzarini G; Carniti E; Fiorini L; Iezzi BG
    Clin Ter; 1984 Nov; 111(3):247-50. PubMed ID: 6240365
    [No Abstract]   [Full Text] [Related]  

  • 11. Functionally thrombasthenic state in normal platelets following the administration of ticlopidine.
    Di Minno G; Cerbone AM; Mattioli PL; Turco S; Iovine C; Mancini M
    J Clin Invest; 1985 Feb; 75(2):328-38. PubMed ID: 3156146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence on lipoprotein metabolism of the platelet inhibitory drug ticlopidine.
    Berglund U; Wallentin L
    Atherosclerosis; 1986 Mar; 59(3):241-6. PubMed ID: 3516163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of policosanol and ticlopidine in patients with intermittent claudication: a double-blinded pilot comparative study.
    Castaño G; Más R; Gámez R; Fernández L; Illnait J
    Angiology; 2004; 55(4):361-71. PubMed ID: 15258682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study of platelet aggregation measured with 3 different methods (photometric and impedance) in ticlopidine treated patients.
    Lecrubier C; Girard P; Noire P; Samama M
    Agents Actions Suppl; 1984; 15():60-7. PubMed ID: 6592946
    [No Abstract]   [Full Text] [Related]  

  • 15. Failure of a pure anti-platelet drug to decrease the number of attacks more than placebo in patients with Raynaud's phenomenon.
    Destors JM; Gauthier E; Lelong S; Boissel JP
    Angiology; 1986 Aug; 37(8):565-9. PubMed ID: 2943195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failure of ticlopidine to inhibit deposition of indium-111-labeled platelets on Dacron prosthetic surfaces in humans.
    Stratton JR; Ritchie JL
    Circulation; 1984 Apr; 69(4):677-83. PubMed ID: 6230173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ticlopidine: a promise for the prevention and treatment of thrombosis and its complications.
    Panak E; Maffrand JP; Picard-Fraire C; Vallée E; Blanchard J; Roncucci R
    Haemostasis; 1983; 13 Suppl 1():1-54. PubMed ID: 6642292
    [No Abstract]   [Full Text] [Related]  

  • 18. Metabolic side effects of the platelet-inhibitory drug ticlopidine.
    Berglund U; Wallentin L
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():281-3. PubMed ID: 3159214
    [No Abstract]   [Full Text] [Related]  

  • 19. The in vitro effect of ticlopidine on fibrinogen and factor VIII binding to human platelets.
    Lee H; Paton RC; Ruan C; Caen JP
    Thromb Haemost; 1981 Oct; 46(3):590-2. PubMed ID: 6797089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effects of ticlopidine on lower limb blood flow, ankle/brachial index and symptoms in peripheral arteriosclerosis. A double-blind study. The STIMS Group in Lund. Swedish Ticlopidine Multicenter Study.
    Fagher B
    Angiology; 1994 Sep; 45(9):777-88. PubMed ID: 8092543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.